medigraphic.com
SPANISH

Revista CONAMED

ISSN 2007-932X (Electronic)
Órgano Oficial de Difusión de la Comisión Nacional de Arbitraje Médico
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 2

<< Back Next >>

Rev CONAMED 2021; 26 (2)

Family functionality in the therapeutics adherence of the patient with systemic arterial hypertension in the first level of attention

Becerra PEN, Villegas GC
Full text How to cite this article 10.35366/100348

DOI

DOI: 10.35366/100348
URL: https://dx.doi.org/10.35366/100348

Language: Spanish
References: 15
Page: 57-67
PDF size: 177.78 Kb.


Key words:

Family functionality, FF-SIL, therapeutic adherence, systemic arterial hypertension.

ABSTRACT

Introduction: Systemic arterial hypertension and its prevalence in Mexico are one of the main factors of cardiovascular events, directly affecting quality of life. Controlling the disease at the first level of attention constitutes a therapeutic strategy that should encourage the patient to adhere to good treatment. The social environment of the patient is of equal importance, mainly in the familiar environment, providing support and security or, conflicts and problems that affect the evolution of the disease. Objective: To know the family functionality in the therapeutic adherence of the patient with systemic arterial hypertension in the family medicine unit #78 in Guadalajara, Jalisco, Mexico. Material and Methods: An observational, descriptive, cross-sectional, prospective correlational study was conducted in which sociodemographic variable instruments were applied, as well as the Therapeutic Adherence Scale for Chronic Patients based on Explicit Behaviors, and the test of family functionality perception (FF-SIL), to all hypertensive patients who go to the outpatient clinic of the Family Medicine Unit #78, with prior informed consent. The universe contemplated was 2705 patients, of which a sample of 336 patients was obtained, with a 95% confidence interval for a type I error of 5%, expressed with a value of 0.05. The statistical analysis was performed with the SPSS software version 19, presenting the data in a descriptive statistic, which includes percentages for the most common central tendency and dispersion measures. Kruskal Wallis H test and Chi square test were used for the non-parametric intervening variables. When the distribution of both variables was normal, Pearson´s correlation was used, and otherwise Spearman´s correlation was applied. Results: A total population of 336 patients was studied; with a majority age range of 60-69 years. In determination family functionality, there it a trend in the increase on systemic blood pressure related to family dysfunction, with an average blood pressure being 130/78 mmHg in the group that qualify for severely dysfunctional family. Regarding the evolution time, a tendency to increase in years of diagnosis in relation to family dysfunction was observed with an average of 10.2 years of evolution with SAH for those with functional families, in contrast to 12.67 years in a severely dysfunctional family. In the main importance variables for the study, adherence to treatment showed a mean of 76.4 points ± 8.6. 89.6% showed high adherence to treatment and 10.42% showed moderate adherence. The FF-SIL scale showed a frequency of 54% with functional families, 37.2% moderately functional, 7% dysfunctional and 0.9% severely dysfunctional. Conclusions: The study showed that good family functionality promotes and preserves the health of the individual, which is linked to adherence and good attachment to lifestyle changes, having a significant impact on the group and individual well-being of the patient. Given the close relationship observed between therapeutic adherence with the family, it is essential to present a project focused on directing efforts in the field of prevention to health managers.


REFERENCES

  1. Diagnóstico y Tratamiento de la hipertensión arterial en el Primer Nivel de Atención México: Instituto Mexicano del Seguro Social; 08/07/2014 [Acceso el 29 Ago 2018]. Disponible en: http://www.cenetec-difusion.com/CMGPC/IMSS-076-08/ER.pdf.

  2. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison HC et al. 2017 Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2017, 23976; doi: 10.1016/j.jacc.2017.07.

  3. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311 (5): 507-520. doi: 10.1001/jama.2013.284427.

  4. Rosas-Peralta M, Palomo-Piñón S, Borrayo-Sánchez G, Madrid-Miller A, Almeida-Gutiérrez E, H Galván OH et al. Consenso de hipertensión arterial sistémica en México. Rev Med Inst Mex Seguro Soc. 2016; 54 (Supl 1): S7-10.

  5. Olvera AS, Müggenburg M, Vigil R. Adherencia terapéutica y funcionalidad familiar en personas con hipertensión arterial. Biblioteca Las Casas, 2014; 10 (2). Disponible en http://www.index-f.com/lascasas/documentos/lc0771.php.

  6. Cazorla MN, Rodríguez D. Grado de adherencia terapéutica a los fármacos del metabolismo óseo-mineral: ¿toman nuestros pacientes la medicación prescrita? Enferm Nefrol [Revista en línea]. 2013 [Acceso agosto 2018]; 16 (1): 7. Disponible en: http://scielo.isciii.es/pdf/enefro/v16n1/07_original6.pdf.

  7. Libertad de Los Ángeles M, Grau JA, Espinosa AD. Marco conceptual para la evaluación y mejora de la adherencia a los tratamientos médicos en enfermedades crónicas. Rev Cubana Salud Pública [En línea]. 2014 [acceso agosto 2018]; 40 (2): 3-4. Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/rt/printerFriendly/46/32.

  8. Jiménez L, Siverio D, Chala JM, Brito Y, Armada Z. Factores relacionados con la no adherencia al tratamiento farmacológico en hipertensos del Policlínico XX Aniversario. Diseño de un programa educativo. CorSalud [Revista en línea]. 2017 [acceso agosto 2018]; 9 (1): 2-3. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/rt/printerFriendly/211/588.

  9. Pomares AJ, Vázquez MA, Ruíz ES. Adherencia terapéutica en pacientes con hipertensión arterial. Rev Finaly [En línea]. 2017 [Acceso Agosto 2018]; 7 (2): 3-4. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342017000200003.

  10. Montoya J, Calvache R. Reflexiones en torno a la adherencia al tratamiento. Revista Psicoespacios. 2014; 8 (13): 256-273. Disponible en http://revistas.iue.edu.co/index.php/Psicoespacios.

  11. Gonzáles-Castro P. El apoyo familiar en la adherencia al tratamiento nutricional del paciente con diabetes mellitus tipo 2 (DM2). Waxapa [En línea]. 2011 [acceso agosto 2018]; 2 (5): 1-5. Disponible en: www.medigraphic.com/pdfs/waxapa/wax-2011/wax115e.pdf.

  12. Cid MC, Montes de Oca R, Hernandez O. La familia en el estado de salud. Rev Med Electrón [En línea]. 2014 [Acceso agosto 2018]; 36 (4): 1-7. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242014000400008.

  13. Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, Durazo-Arvizu R et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica de Mexico. 2010; 52 (S1): S63-S71.

  14. Arévalo MT, Claro NO, Rotela CA. Relación entre conocimientos en hipertensión arterial y factores de riesgo cardiovasculares con estilos de vida saludables. Revista virtual de postgrado. Facultad de Medicina; Universidad Nacional de Itapúa. 2016; 1 (1): 5-7.

  15. Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J. Harrison, principios de medicina interna. 20a ed. McGrawHill; 2018.




Table 1
Table 2
Table 3
Table 4
Table 5
Table 6
Table 7
Table 8

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev CONAMED. 2021;26